Clinical trial
Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
NCT00206375 · Baylor College of Medicine, Other · Terminated
Key facts
| NCT number | NCT00206375 |
|---|---|
| Title | Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism |
| Official title | Concomitant Use of Growth Hormone and GnRH Agonist in Adolescent Patients With Acquired Hypothyroidism |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | Eli Lilly and Company Industry TAP Pharmaceutical Products Inc. |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypothyroidism |
| Intervention type | Drug |
| Interventions | Growth hormone, Growth hormone treatment and puberty |
| Enrollment | 16 |
| Start date | May 1, 2003 |
| Primary completion | Sep 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Sep 21, 2005 |
| Last update posted | Oct 30, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: